Predicting Response and Toxicity in Patients Receiving Paclitaxel and Avastin for Breast Cancer
Status: TERMINATED
Study type: OBSERVATIONAL
Conditions: Breast Cancer
Interventions: PROCEDURE: Core Biopsy|PROCEDURE: Blood Collection|DRUG: Paclitaxel|DRUG: Avastin
Sponsor: Hoosier Cancer Research Network
Collaborators: United States Department of Defense|Indiana University School of Medicine|University of Colorado, Denver|Baylor University|McGill University